These findings support the role of NF-κB in MAT2A gene transcription and suggest the underlying mechanism of enhanced NF-κB activity to be related to miR-146b down-regulation in TAM-resistant breast cancer. The gene discussed is MAT2A; the disease is breast carcinoma.